Skip to main content

Table 1 Primary and secondary outcomes

From: A randomised controlled trial to evaluate and optimize the use of antiplatelet agents in the perioperative management in patients undergoing general and abdominal surgery- the APAP trial (ISRCTN45810007)

Primary endpoints

Definition and assessment of outcomes

Perioperative thromboembolic event

 

Perioperative bleeding complication

Occurrence of critical blood-loss requiring surgical intervention or the application of coagulation products (FFP, coagulation factors) to normalize the INR

Secondary endpoints

Definition and assessment of outcomes

Operation time [min]:

Time from skin incision to placement of last skin staple/suture.

Intraoperative blood loss [ml]:

Blood loss observed from skin incision to placement of last staple/suture.

Duration of postoperative hospital stay [days]:

Time from day of surgery to day of discharge.

Morbidity/

 

Surgical complications

 

Medical complications

 

Peri-/postoperative need for blood/coagulation products

 

Re-laparotomy/laparoscopy

Re-operation within the time of index hospitalization respectively within the time of follow-up after the index operation.

In-hospital mortality:

Death due to any reason within the patient's initial hospital stay.

Readmisson